NUZ 2.38% 20.5¢ neurizon therapeutics limited

Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL, page-37

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 147 Posts.
    lightbulb Created with Sketch. 46
    From a vets perspective , I would be extremely interested to see if they would consider an MPL trial on cats for FIP , it is caused by feline coronavirus and given the good results so far in vitro on Covid this would be huge if it worked . Currently there is no approved treatment and the disease is 100 % fatal . There has been some succes with using Remdesivir for treatment and another highly experimental drug that can only be obtained on black market in China .
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.005(2.38%)
Mkt cap ! $99.76M
Open High Low Value Volume
20.5¢ 21.0¢ 20.5¢ $20.93K 102.1K

Buyers (Bids)

No. Vol. Price($)
1 36959 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 71032 2
View Market Depth
Last trade - 16.10pm 28/10/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.